Screener
UroGen Pharma URGN Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $72,456 | $24,215 | $123,415 | $44,469 |
| Cost of revenue | 6,572 | 3,550 | 10,711 | 5,880 |
| Gross profit | 65,884 | 20,665 | 112,704 | 38,589 |
| Operating expenses: | ||||
| Research and development expenses | 17,336 | 18,914 | 32,933 | 38,785 |
| Selling, general and administrative expenses | 48,437 | 43,199 | 99,923 | 78,166 |
| Operating income (loss) | 111 | (41,448) | (20,152) | (78,362) |
| Financing on prepaid forward obligation | (4,545) | (4,644) | (9,051) | (9,227) |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's total revenue?
- UroGen Pharma (URGN) reported total revenue of $72.46M in Q2 2026.
- How has UroGen Pharma's total revenue changed year-over-year?
- UroGen Pharma's total revenue increased by 199.2% year-over-year, from $24.22M to $72.46M.
- What is the long-term trend for UroGen Pharma's total revenue?
- Over 4 years (2021 to 2025), UroGen Pharma's total revenue has grown at a 23.0% compound annual growth rate (CAGR), from $48.04M to $109.79M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about UroGen Pharma's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude